US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Latest News about NASDAQ:PGEN

Recent news which mentions NASDAQ:PGEN

PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q2 2024
Tickers PGEN
Tags NASDAQ:PGEN PGEN Market News
From InvestorPlace
PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q1 2024
Tickers PGEN
Tags NASDAQ:PGEN PGEN Market News
From InvestorPlace
PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023
Tickers PGEN
Tags NASDAQ:PGEN Today's Market PGEN
From InvestorPlace
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
Tickers PGEN
Tags NASDAQ:PGEN
From News Direct
Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
Tickers ALLO BMY CRBU CRSP
Tags NASDAQ:PGEN
From News Direct